CATAMARAN BIO

catamaran-bio-logo

Catamaran Bio is a biotechnology company that specializes in allogeneic immune cell therapies. It offers cell therapy company developing allogeneic, off-the-shelf products for patients with an unmet medical need. It was founded in 2020 and headquartered in Cambridge, Massachusetts.
#SimilarOrganizations #People #Financial #Event #Website #More

CATAMARAN BIO

Social Links:

linkedin

Linkedin

Industry:
Biopharma Biotechnology Health Care

Founded:
2020-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.catamaranbio.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
42 M USD

Technology used in webpage:
Mimecast


Similar Organizations

arcellx-logo

Arcellx

Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.

day-one-biopharmaceuticals-logo

Day One Biopharmaceuticals

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.

dyno-therapeutics-logo

Dyno Therapeutics

Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.

remix-therapeutics-logo

Remix Therapeutics

Remix Therapeutics is a biotechnology company.

tango-therapeutics-logo

Tango Therapeutics

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.


Current Advisors List

michael-briskin_image

Michael Briskin Advisor @ Catamaran Bio
Advisor
2020-04-01

Current Employees Featured

vipin-suri_image

Vipin Suri
Vipin Suri CSO @ Catamaran Bio
CSO
2020-03-01

mark-boshar_image

Mark Boshar
Mark Boshar COO @ Catamaran Bio
COO
2020-01-01

kevin-pojasek_image

Kevin Pojasek
Kevin Pojasek Founder & Executive Chairman @ Catamaran Bio
Founder & Executive Chairman
2020-03-01

mike-deridder_image

Mike DeRidder
Mike DeRidder SVP, Corporate Strategy and New Product Planning @ Catamaran Bio
SVP, Corporate Strategy and New Product Planning
2022-02-01

scott-holmes_image

Scott Holmes
Scott Holmes Chief Financial Officer @ Catamaran Bio
Chief Financial Officer
2021-04-01

alvin-shih_image

Alvin Shih
Alvin Shih President and Chief Executive Officer @ Catamaran Bio
President and Chief Executive Officer
2021-02-01

houman-ashrafian_image

Houman Ashrafian
Houman Ashrafian Director @ Catamaran Bio
Director
2020-01-01

branden-s-moriarity_image

Branden S. Moriarity
Branden S. Moriarity Scientific Co-Founder @ Catamaran Bio
Scientific Co-Founder

tara-place_image

Tara Place
Tara Place VP, Human Resources and Organizational Effectiveness @ Catamaran Bio
VP, Human Resources and Organizational Effectiveness
2021-11-01

joseph-gold_image

Joseph Gold
Joseph Gold Vice President, Technical Operations and Manufacturing @ Catamaran Bio
Vice President, Technical Operations and Manufacturing
2021-08-01

Founder


branden-s-moriarity_image

Branden S. Moriarity

kevin-pojasek_image

Kevin Pojasek

Investors List

astellas-venture-management_image

Astellas Venture Management

Astellas Venture Management investment in Series A - Catamaran Bio

lightstone-ventures_image

Lightstone Ventures

Lightstone Ventures investment in Series A - Catamaran Bio

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Series A - Catamaran Bio

takeda-ventures_image

Takeda Ventures

Takeda Ventures investment in Series A - Catamaran Bio

sofinnova-partners_image

Sofinnova Partners

Sofinnova Partners investment in Series A - Catamaran Bio

Official Site Inspections

http://www.catamaranbio.com Semrush global rank: 4.01 M Semrush visits lastest month: 3.09 K

  • Host name: 160.26.180.107.host.secureserver.net
  • IP address: 107.180.26.160
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Catamaran Bio"

Home - Catamaran Bio

Apr 11, 2023 At Catamaran, our guiding focus is to drive innovation in cell therapy to treat more patients. Our scientific founders, Branden Moriarity, PhD …See details»

Catamaran Bio - Crunchbase Company Profile & Funding

Contact Email [email protected] Catamaran Bio is a biotechnology company that specializes in allogeneic immune cell therapies. It offers cell therapy company developing …See details»

CCRM. Benefitting from CCRM’s existing expertise, OmniaBio …

Mar 14, 2023 please visit catamaranbio.com and follow Catamaran on LinkedIn and @CatamaranBio on Twitter. About OmniaBio OmniaBio Inc. is a contract development and …See details»

Company Overview - Catamaran Bio

Our TAILWIND ®. Catamaran has developed TAILWIND ®, a proprietary and integrated suite of technologies, to engineer, expand and process NK cells …See details»

Catamaran Bio - LinkedIn

Catamaran Bio | 4,145 followers on LinkedIn. Cell therapy company developing allogeneic, off-the-shelf products for patients with high unmet medical need | At Catamaran, our mission is to harness ...See details»

Catamaran Bio Company Profile | Management and Employees List …

[email protected]: Catamaran Bio Top Competitors. Company Employees Revenue Top technologies; SpherIngenics Inc. 6: $982 K: Minerva Biotechnologies Corp. 17: $4 M: …See details»

Catamaran Bio 2025 Company Profile: Valuation, …

Information on valuation, funding, cap tables, investors, and executives for Catamaran Bio. Use the PitchBook Platform to explore the full profile.See details»

Catamaran Bio - Overview, News & Similar companies - ZoomInfo

Mar 14, 2023 Catamaran Bio selects OmniaBio as partner to develop and manufacture allogeneic CAR-NK cell therapies BOSTON & TORONTO--(BUSINESS WIRE)--Catamaran …See details»

Catamaran Bio - Craft

Catamaran Bio is a cell therapy company developing allogeneic, off-the-shelf products for patients with unmet medical needs. It creates drugs designed to treat a broad range of cancers, …See details»

Catamaran Bio Company Profile: Overview and Full News Analysis

News Summary Catamaran Bio Inc. is a biotechnology company developing off-the-shelf NK cell therapies to treat cancer . OmniaBio Inc., a contract development and manufacturing …See details»

Catamaran Bio - workinbiotech.com

Catamaran Bio is developing off-the-shelf chimeric antigen receptor (CAR) natural killer (NK) cell therapies to address a broad range of cancers. NK cells are critical components of the immune …See details»

Catamaran Bio selects OmniaBio as partner to develop and …

For more information, please visit catamaranbio.com and follow Catamaran on LinkedIn and @CatamaranBio on Twitter. About OmniaBio OmniaBio Inc. is a contract development and …See details»

Catamaran Bio — Sofinnova Partners

Apr 4, 2022 catamaranbio.com. Maina Bhaman. Partner, Sofinnova Partners - Capital Strategy. Related News. 11 April, 2023 Catamaran Bio Announces Preclinical Data from Allogeneic …See details»

Catamaran Bio Company Overview, Contact Details & Competitors …

Nov 23, 2020 Catamaran Bio, Inc. is developing off-the-shelf chimeric antigen receptor-natural killer cell therapies on Mar 14th '23. Catamaran Bio Inc., a biotechnology company developing …See details»

Catamaran Bio selects OmniaBio as partner to develop and …

Mar 14, 2023 Contacts. For more information or to arrange an interview, please contact: Catamaran Bio, Inc. Michael DeRidder +1 (267) 496 6534 [email protected] …See details»

Catamaran Bio selects OmniaBio as partner to develop and

Mar 14, 2023 For more information, please visit catamaranbio.com and follow Catamaran on LinkedIn and @CatamaranBio on Twitter. About OmniaBio. OmniaBio Inc. is a contract …See details»

Catamaran Bio Announces Lead CAR-NK Cell Therapy ... - Business …

Nov 4, 2021 Catamaran contact: Mark Boshar, Chief Operating Officer 617-620-9709 [email protected] Media Contact: Kathryn Morris, The Yates Network 914-204-6412 …See details»

Catamaran Bio Presents Preclinical Data Supporting CAT-248, an …

For more information, please visit www.catamaranbio.com and follow us on LinkedIn and @CatamaranBio on Twitter. Catamaran contact: Mark Boshar, Chief Operating Officer 617 …See details»

Establishing Canada’s first large-scale bioinnovation centre

2 days ago The Neptune BioInnovation Centre (NBC), a 51,000 sq ft facility on a 12.3 acre lot in Dartmouth, will offer leasable wet and dry lab space, warehouse and office spaces, and …See details»

Catamaran Bio Presents Preclinical Efficacy Data for ... - Business …

Nov 10, 2022 Catamaran Contact: Mark Boshar, Chief Operating Officer 617-620-9709 [email protected] Media Contact: Kathryn Morris, The Yates Network 914-204-6412 …See details»

linkstock.net © 2022. All rights reserved